Retrospective Analysis of Tacrolimus Levels: The First 56 Days Following Allogeneic Hematopoietic Stem Cell Transplant and Patient Outcomes
Overall, we found that higher levels of tacrolimus (range 8-12 ng/mL) in the first 8 weeks post-transplant were associated with improved outcomes without increased rate of relapse.
Authors
- Joseph Bubalo (ORCID: https://orcid.org/0000-0002-7873-1597)
- Jennifer N. Saultz (ORCID: https://orcid.org/0000-0003-0024-9466)
- Pavani Malla
- Kateryna Kovalenko
Institutions
- Oregon Health & Science University (US)
- UC San Diego Health System (US)
Publication Details
- Journal
- Annals of Pharmacotherapy
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1177/10600280251321324
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00